Insulin aspart - Novo Nordisk
At a glance
- Drug Originator ZymoGenetics
- Drug Licenced by Novo Nordisk
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones; Peptides
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
- USA Patent Applicants NOVO NORDISK INC
- USA Patents 24
- BLAs 1
- International Patents 459
Disclaimer